share_log

Cantor Fitzgerald Reiterates Overweight on PDS Biotechnology

Benzinga ·  May 9 11:12

Cantor Fitzgerald analyst Louise Chen reiterates PDS Biotechnology (NASDAQ:PDSB) with a Overweight.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment